Mechanism of Action

Defactinib hydrochloride (also known as VS-6063) acts as an ATP-competitive inhibitor of focal adhesion kinase (FAK) and the related non-receptor tyrosine kinase PYK2. FAK is a cytoplasmic tyrosine kinase that plays a central role in integrin-mediated signal transduction, regulating cell adhesion, proliferation, survival, and migration. By binding to the ATP-binding pocket of FAK, Defactinib hydrochloride prevents autophosphorylation at the Y397 residue, thereby blocking downstream signaling cascades including the PI3K/AKT and RAS/MAPK pathways.

Inhibition of FAK signaling disrupts key pro-tumorigenic processes such as epithelial-to-mesenchymal transition (EMT), cancer stem cell maintenance, and immunosuppressive remodeling of the tumor microenvironment. PYK2 inhibition may contribute additional effects on osteoclast function, hematopoietic cell signaling, and neuronal plasticity in relevant model systems.

Preparation and Handling Guidelines

Stock Solution Preparation: Defactinib hydrochloride is supplied as a solid powder. For initial dissolution, prepare a concentrated stock solution in DMSO (typically 10–50 mM) by vortexing and, if necessary, sonicating briefly at room temperature. The hydrochloride salt form also confers aqueous solubility; verify the actual solubility in your specific buffer system at the target concentration before use. Always perform a clarity check prior to dilution.

Working Solution Preparation: Dilute the DMSO stock into aqueous cell culture media or assay buffers immediately before use. Ensure that the final DMSO concentration does not exceed 0.1–0.5% (v/v) to avoid cytotoxic artifacts. Prepare fresh working solutions where possible or store aliquots at -20 °C and avoid repeated freeze-thaw cycles.

Safety Precautions: Handle Defactinib hydrochloride following standard laboratory safety protocols for potent bioactive small molecules. Wear appropriate PPE (gloves, lab coat, eye protection). Consult the Safety Data Sheet (SDS) before use. Dispose of waste in compliance with institutional and local regulations.

Storage: Store the bulk powder at -20 °C in a tightly sealed, desiccated container protected from light and moisture. Under recommended storage conditions, the compound maintains stability for an extended period; however, confirm compound integrity periodically by analytical methods if long-term storage is intended.

Research Applications

Defactinib hydrochloride is widely used in preclinical research settings to dissect FAK-dependent signaling in cancer biology and beyond:

• Tumor Cell Biology: Investigating FAK's role in cancer cell adhesion, anoikis resistance, proliferation, and survival in solid tumor models including lung, ovarian, pancreatic, and mesothelioma cancer cell lines.
• Tumor Microenvironment (TME): Studying FAK-mediated immunosuppression, including regulatory T-cell (Treg) accumulation and myeloid-derived suppressor cell (MDSC) function, with implications for immuno-oncology combination strategies.
• Metastasis and Migration Assays: Scratch-wound healing, Transwell invasion, and 3D matrix invasion assays to quantify the role of FAK/PYK2 signaling in cancer cell motility.
• Cancer Stem Cells (CSC): Evaluating the contribution of FAK signaling to stemness maintenance, sphere-forming capacity, and drug resistance.
• Mechanobiology: Probing integrin-FAK signaling in response to extracellular matrix stiffness and mechanical stimuli.
• Combination Studies: Pairing with chemotherapy agents, KRAS inhibitors, checkpoint inhibitors, or other targeted therapies to assess synergistic or additive anti-tumor effects in vitro and in vivo.

Quality, Purity & Regulatory Considerations

Defactinib hydrochloride (SKU: D656186) is supplied by Aladdin Scientific as a research-grade reagent. Users should note the following:

• Purity: Confirm the certificate of analysis (CoA) for lot-specific purity data (typically assessed by HPLC). Cross-reference with the supplier's CoA before initiating critical experiments.
• Research Use Only: This compound is intended solely for in vitro and in vivo preclinical research purposes. It is not approved, certified, or intended for use in diagnostic procedures, therapeutic applications, or any clinical use in humans or animals without appropriate regulatory authorization.
• Lot-to-Lot Consistency: For longitudinal studies, record the lot number and request matching lots where reproducibility is critical.
• Analytical Verification: Consider confirming compound identity and purity by NMR or LC-MS prior to use in key experiments, particularly for long-stored aliquots.

Frequently Asked Questions

See the FAQ section below for common questions about Defactinib hydrochloride preparation, selectivity, and experimental design.